Kala Pharmaceuticals to Present at the Jefferies 2020 Virtual London Healthcare Conference
To access a live webcast and subsequent archived recording of the presentation, please visit the “Events” in the “Investors” section of the Kala website at http://kalarx.com
About
Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus penetrating particle Drug Delivery Technology to a corticosteroid, loteprednol etabonate (LE), designed for ocular applications, resulting in the
View source version on businesswire.com: https://www.businesswire.com/news/home/20201111005050/en/
Investors:
loraine.spreen@kalarx.com
857-277-4842
hannah.deresiewicz@sternir.com
212-362-1200
Source: